Lancaster Cancer Center, Ltd.

Lancaster, Pennsylvania 17605

0 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular, Multiple Myeloma, Myelodysplastic Syndromes, Non-Hodgkin's Lymphoma, Prostate Cancer

Studies at this site

• An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) — Completed
• Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma — Stopped early
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) — Stopped early
• Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma — Completed
• Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma — Stopped early
• GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer — Stopped early
• A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes — Completed